United States securities and exchange commission logo





                               January 7, 2021

       Sean Carrick
       Chief Executive Officer
       Nascent Biotech Inc.
       25350 Magic Mountain Parkway Suite 250
       Santa Clarita, CA 91355

                                                        Re: Nascent Biotech
Inc.
                                                            Amendment No. 1 to
Form S-1
                                                            Filed December 31,
2020
                                                            File No. 333-251525

       Dear Mr. Carrick:

            We have reviewed your amended registration statement and have the
following
       comment.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comment applies to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to the comment, we may have additional comments.

       Amendment No. 1 to Form S-1

       General

   1.                                                   The fee table and the
revised legal opinion indicate that a total of 30,000,000 shares are
                                                        being registered for
sale on the registration statement while the cover page of the
                                                        prospectus and selling
security holders table on page 16 indicate that 33,700,000 shares
                                                        are being offered for
sale pursuant to the prospectus. Please revise so that the correct
                                                        amount of shares is
reflected throughout. Please also revise the legal opinion to reflect the
                                                        correct filing date for
the registration statement.
 Sean Carrick
FirstName  LastNameSean Carrick
Nascent Biotech Inc.
Comapany
January    NameNascent Biotech Inc.
        7, 2021
January
Page 2 7, 2021 Page 2
FirstName LastName
       Please contact Chris Edwards at 202-551-6761 or Joe McCann at
202-551-6262 with any
other questions.



                                                        Sincerely,

                                                        Division of Corporation
Finance
                                                        Office of Life Sciences
cc:      Claudia J. McDowell, Esq.